Citations

Showing 10 of 108152 citations.

Cardiac memory for the clinical electrophysiologist
Siontis, Konstantinos C. , Wen, Songnan , Asirvatham, Samuel J. , Asirvatham, Samuel J

Mayo Clinic

Journal of Cardiovascular Electrophysiology | September 3, 2019 | Volume: 30 | Issue: 10 | Pages: 2140-2143

10.1111/jce.14134 | PMID 31478287 Get It

Arrhythmias in hematopoietic stem cell transplantation: A systematic review and meta‐analysis
Chiengthong, Kanhatai , Lertjitbanjong, Ploypin , Cheungpasitporn, Wisit , Sharma, Konika , Chokesuwattanaskul, Ronpichai , Chokesuwattanaskul, Ronpichai , Cheungpasitporn, Wisit , Thongprayoon, Charat , Prasitlumkum, Narut , Mao, Michael A.

Mayo Clinic

European Journal of Haematology | September 3, 2019 | Volume: 103 | Issue: 6 | Pages: 564-572

10.1111/ejh.13322 | PMID 31478231 Get It

Abstract Background There are controversial data regarding the relationship between hematopoietic stem cell transplantation and arrhythmias. This meta‐analysis was performed to evaluate the incidence of arrhythmias in patients following hematopoietic stem cell transplantation (HSCT). Methods A literature search was conducted utilizing MEDLINE, EMBASE, and Cochrane Databases from inception through April 2019. Pooled incidence with 95% confidence interval (CI) were calculated using random‐effects meta‐analysis. The protocol for this meta‐analysis is registered with PROSPERO (International Prospective Register of Systematic Reviews; no. CRD42019131833). Results Thirteen studies consisting of 10,587 patients undergoing HSCT were enrolled in this systematic review. Overall, the pooled estimated incidence of all types of arrhythmias following HSCT was 7.2% (95% CI: 4.9%‐10.5%). With respect to the most common type of arrhythmia, the pooled estimated incidence of atrial fibrillation/atrial flutter (AF/AFL) within 30 days following HSCT was 4.2% (95% CI: 1.7%‐9.6%). Egger's regression test demonstrated no significant publication bias in this meta‐analysis of post‐HSCT arrhythmia incidence. Conclusion The overall estimated incidence of arrhythmias following HSCT was 7.2%. Future large scale studies are needed to further elucidate the significance and clinical impact of arrhythmias in post‐HSCT patients.
Timing of ergogenic aids and micronutrients on muscle and exercise performance
Stecker, Richard A., Candow, Darren G. , Kerksick, Chad M. , Kerksick, Chad M , Harty, Patrick S. , Jagim, Andrew R.

Mayo Clinic

Journal of the International Society of Sports Nutrition | September 2, 2019 | Volume: 16 | Issue: 1 | Pages: No page available

10.1186/s12970-019-0304-9 | PMID 31477133 Get It

Faculty Opinions recommendation of Major neurologic complications associated with postdural puncture headache in obstetrics: A retrospective cohort study.
Sviggum, Hans P.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 2, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736245329.793564424 Get It

Plasma extracellular vesicles as phenotypic biomarkers in prostate cancer patients
Joncas, France‐Hélène, Rouleau, Mélanie , Morin, Fannie, Leong, Hon S. , Pouliot, Frédéric , Fradet, Yves , Gilbert, Caroline , Toren, Paul , Lucien, Fabrice , Leong, Hon S , Toren, Paul , Fradet, Yves , Lucien, Fabrice

Mayo Clinic

The Prostate | September 2, 2019 | Volume: 79 | Issue: 15 | Pages: 1767-1776

10.1002/pros.23901 | PMID 31475741 Get It

AbstractBackgroundThe development of phenotypic biomarkers to aid the selection of treatment for patients with castrate‐resistant prostate cancer (CRPC) is an important priority. Plasma exosomes have excellent potential as real‐time biomarkers to characterize the tumor because they are easily accessible in the blood and contain DNA, RNA, and protein from the parent cell. This study aims to investigate the characteristics of putative prostate‐specific plasma extracellular vesicle (EV) markers and their relationship with clinical outcomes.Methods and PatientsWe investigated plasma EVs in a total of 89 patients with prostate cancer (PCa) at different stages of disease progression. EVs were isolated using both precipitation and ultracentrifugation methods; physical characterization was performed using dynamic light scattering, acetylcholinesterase (AChE) activity, and velocity gradients. An immunocapture method was developed for the evaluation of prostate‐specific membrane antigen (PSMA)‐positive exosomes. Exosomal messenger RNA (mRNA) was quantified using droplet digital polymerase chain reaction for the expression of KLK3 and androgen receptor splice variant 7 (AR‐V7) genes, which code prostate‐specific antigen (PSA) and AR‐V7, respectively. Serum sex steroids were measured using liquid chromatography‐tandem mass spectroscopy.ResultsIsolated exosomes from patients with CRPC had a smaller hydrodynamic size than those isolated from localized patients with PCa, while AChE activity showed no difference. Moreover, no differences were observed after initiation of androgen deprivation therapy in serial patient samples. Velocity gradients identified that PSMA‐positive exosomes occupied a specific fraction of isolated EVs. A total of 35 patients with CRPC had mRNA analyzed from isolated plasma exosomes. Detectable exosomal KLK3 corresponded with higher concomitant serum PSA measurements, as expected (mean, 112.6 vs 26.61 ng/mL; P = .065). Furthermore, detectable levels of AR‐V7 mRNA were associated with a shorter time to progression (median, 16.0 vs 28.0 months; P = .0499). Furthermore, detectable exosomal AR‐V7 was significantly associated with testosterone levels below the lower limit of quantification (<0.1 nM).ConclusionsOur results suggest that exosomal AR‐V7 is correlated with lower sex steroid levels in CRPC patients with a poorer prognosis. PSMA immunocapture does not appear sufficient to isolate PCa‐specific exosomes.
Evolution of Hip Dysplasia in Pediatric Patients With Prader-Willi Syndrome Treated With Growth Hormone Early in Development
Tibbo, Meagan E. , Ibnoulkhatib, A., Kerezoudis, Panagiotis , Diene, Gwénaëlle , Lemoine, Camille Thévenin, Gauzy, Jérôme Sales de , Laumonerie, Pierre , Accadbled, Franck

Mayo Clinic

Journal of Pediatric Orthopaedics | September 2, 2019 | Volume: 40 | Issue: 5 | Pages: e357-e361

10.1097/bpo.0000000000001443 | PMID 31479030 Get It

Background: Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by obesity, hypotonia, feeding difficulties, obesity, musculoskeletal manifestations including scoliosis, and hip dysplasia (HD). The aim of this study was to characterize the clinical and radiographic evolution of HD in the pediatric PWS population. Methods: The authors performed a retrospective cohort study of 72 patients (147 anteroposterior pelvic radiographs) between January 2004 and December 2016. Center-edge angle (CEA) of Wiberg, acetabular index (AI), and neck-shaft angle (NSA) were measures in all hips. The relationship between radiographic and demographic parameters of age, sex, and body mass index z-score (BMIzs) were assessed. Results: A total of 274 radiographic measurements were performed and analyzed in 72 patients. The mean CEA, AI, and NSA were 21.8±7.1 degrees (range, 5 to 35 degrees), 16.7±7 degrees (range, 5 to 45 degrees), and 142±8.5 degrees (range, 128 to 165 degrees), respectively. HD was diagnosed in 79 (29%) hip radiographs and varied significantly between the age groups (P<0.01). A statistically significant association was identified between age and CEA [β coef, 0.80; 95% confidence interval (CI), 0.6-1; P<0.01], AI (β coef, −0.90; 95% CI, −1.1 to −0.7; P<0.01), and NSA (β coef, −1.11; 95% CI, −1.4 to −0.9; P<0.01) angles. Sex and BMIzs were not identified as independent predictors of radiographic hip angles (P>0.1). Conclusions: The present study demonstrated favorable evolution of hip radiographic parameters in the PWS population treated with growth hormone early in development. This finding should prompt orthopedists to consider observation alone in the management algorithm for HD in patients with PWS. Levels of Evidence: Level III—a retrospective comparative study.
Glial Fibrillary Acidic Protein (GFAP) Autoimmunity in the Setting of Seropositive Rheumatoid Arthritis Treated With Etanercept
Amin, Shreyasee , Jentoft, Mark E. , Kantarci, Orhun H. , Smith, Kelsey M. , Jones, Lyell K. , Lachance, Daniel Honore , Flanagan, Eoin P.

Mayo Clinic

The Neurologist | September 2, 2019 | Volume: 24 | Issue: 5 | Pages: 152-154

10.1097/nrl.0000000000000243 | PMID 31478999 Get It

Introduction: Glial fibrillary acidic protein (GFAP) immunoglobulin G is a recently discovered biomarker of an autoimmune central nervous system disorder characterized by a steroid-responsive meningoencephalomyelitis. Case Report: A 63-year-old man with rheumatoid arthritis on etanercept presented with steroid-responsive subacute encephalopathy and foot drop. Brain and sural nerve biopsies demonstrated a T-cell perivascular infiltrate. Cerebrospinal fluid studies 18 months into the course of the illness demonstrated a GFAP antibody on mouse tissue immunofluorescence confirmed by cell-based assay. The patient was treated with steroids and cyclophosphamide leading to resolution of his symptoms. Conclusion: This case expands on the previously reported cases of GFAP immunoglobulin G autoimmunity by describing an associated inflammatory large fiber peripheral neuropathy.
Mental health conditions diagnosed before bilateral oophorectomy: a population-based case-control study
Rocca, Liliana Gazzuola , Laughlin-Tommaso, Shannon K., Rocca, Walter A. , Gazzuola Rocca, Liliana, Smith, Carin Y. , Bobo, William V. , Grossardt, Brandon R. , Stewart, Elizabeth A.

Mayo Clinic

Menopause | September 2, 2019 | Volume: 26 | Issue: 12 | Pages: 1395-1404

10.1097/gme.0000000000001413 | PMID 31479036 Get It

Abstract Objective: We studied eight mental health conditions diagnosed before bilateral oophorectomy performed for nonmalignant indications. Methods: We identified 1,653 premenopausal women who underwent bilateral oophorectomy for a nonmalignant indication in Olmsted County, Minnesota, during a 20-year period (1988-2007). Each woman was matched by age (±1 year) to one population-based control who had not undergone bilateral oophorectomy before the index date (age range: 21-49 years). Both cases and controls were identified using the records-linkage system of the Rochester Epidemiology Project (REP http://www.rochesterproject.org). For eight mental health conditions, we calculated odds ratios (ORs) and their 95% confidence intervals (95% CIs) adjusted for race, education, and income using conditional logistic regression. Results: Pre-existing mood disorders, anxiety disorders, and somatoform disorders were associated with increased risk of bilateral oophorectomy in overall analyses. These associations were also significant in women ≤45 years of age at index date. Personality disorders were associated with increased risk only in overall analyses and adjustment disorders only in women 46 to 49 years of age. Some of the associations were significantly different across strata by age at index date and by indication. There was also a linear trend of increasing adjusted ORs from 1.55 (95% CI 1.31-1.83) for one mental health condition to 2.19 (95% CI 1.40-3.41) for three or more conditions (trend P < 0.001). Conclusions: We identified several mental health conditions that were associated with bilateral oophorectomy for nonmalignant indications. Awareness of these associations may guide women and physicians in future decision-making and limit unindicated bilateral oophorectomies. Video Summary: http://links.lww.com/MENO/A458.
Concomitant Erdheim‐Chester disease and chronic myelomonocytic leukaemia: genomic insights into a common clonal origin
Goyal, Gaurav , Liu, Yuanhang , Ravindran, Aishwarya , Al‐Kali, Aref , Patnaik, Mrinal M. , Goyal, Guarav , Ravindran, Aishwarya , Go, Ronald S. , Rech, Karen L.

Mayo Clinic

British Journal of Haematology | September 2, 2019 | Volume: 187 | Issue: 2 | Pages: No page available

10.1111/bjh.16177 | PMID 31475353 Get It

Ulcère Perforé-Bouché
Bazerbachi, Fateh , Chandrasekhara, Vinay

Mayo Clinic

American Journal of Gastroenterology | September 2, 2019 | Volume: 115 | Issue: 5 | Pages: 649-649

10.14309/ajg.0000000000000389 | PMID 31478920 Get It